Malaria Treatment Market Size to Surpass USD 647.13 Million with a Growing CAGR of 6.6% by 2030, Share, Trends, Growth Strategies and Competitive Analysis

"A comprehensive Malaria Treatment Market analysis report provides key statistics on the market status of global and regional manufacturers, serving as a valuable source of guidance for companies and individuals interested in the industry. When making decisions related to revenue, import, export, and consumption, the analysis of company profiles covered in this report proves beneficial. The diligent efforts, coupled with integrated approaches, result in an exceptional market research report that influences the decision-making process of businesses. The top-notch Malaria Treatment Market report incorporates graphical representation throughout to convey numerical information effectively.

This realistic Malaria Treatment Market report offers clear insights into the market potential for each geographical region, considering growth rates, macroeconomic factors, consumer buying patterns, potential future trends, and market demand and supply scenarios. To gain unparalleled and comprehensive insight, along with the best understanding of emerging market opportunities, businesses should refer to this market research report. A credible Malaria Treatment Market report utilizes a combination of advanced industry insights, practical solutions, talent solutions, the latest tools, and technology to provide an excellent user experience.

Data Bridge Market Research analyses a growth rate in the malaria treatment market in the forecast period 2023-2030. The expected CAGR of malaria treatment market is tend to be around 6.6% in the mentioned forecast period.

Explore Further Details about This Research Malaria Treatment Market Report https://www.databridgemarketresearch.com/reports/global-malaria-treatment-market

Malaria Treatment Market Scope and Segmentation
REPORT METRIC

DETAILS

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Agent (Plasmodium Falciparum, P. Vivax, P. Ovale, P. Malariae and P. Knowlelsi), Type (Medication and Vaccination), Treatment Type (Suppressive Treatment and Radical Treatment), Drug Type (Branded and Generics), Route of Administration (Oral and Parenteral), End User (Hospitals, Specialty Clinics, Diagnostic Centers and Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies and Online Pharmacies)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Actiza Pharmaceutical Private Limited (India), Amneal Pharmaceuticals LLC. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Cipla Inc. (India), Lupin (India), Ipca Laboratories Ltd (India), Mylan N.V. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Zydus Group (India), MMV (Switzerland), Novartis AG (Switzerland), Sumaya Biotech (Germany), Taj Pharmaceuticals Limited (India), OSIVAX (France), Strides Pharma Science Limited (India)

Market Opportunities

Increasing Diagnostic Tests For Malaria

Increasing Strategic Alliances and Agreements

Market Definition

Malaria is a kind of deadly infectious disease that is caused by the Plasmodium parasite. The varied medication categories for malaria treatment include primaquine, mefloquine, quinine, chloroquine, hydroxychloroquine, non-artemisinin based combinations (non-acts), artemisinin-based combination therapy (ACT), and others. The incidence of wide range of malaria treatment products will offer a better patient experience with reducing the risk of death.

Malaria Treatment Market Dynamics
Drivers

Rising Prevalence of Malaria

As per tehe statistics of WHO, in 2012, India had the highest incidence of malaria in this region with an estimated 24 million cases every year,which Indonesia followsIndonesia, Pakistan, Myanmar, and Papua New Guinea follow. In the 22 countries in Asia and the Pacific where the disease is predominant, more than 80% of the population is at increased risk of getting malaria. Apart from this, the increasing number of traveller malaria cases is also leading to the demand for the malaria treatment modalities, as every year, thousands of people travel to the malaria-affected region. Thus, this boost the growth of the treatment market.

Increasing Demand of Direct Tender Channel

The direct tender segment is increasing the malaria treatment market since direct tender holds the largest market share combined with the highest CAGR. It is mostly because of the service providers who buy the product from numerous manufacturers and it is noticed that revenue from direct sales is more influential and increasing in the malaria treatment market.

Opportunities

Growing Diagnostic Tests For Malaria

Several companies are manufacturing rapid diagnostic tests with high sensitivity. For instance, numerous researchers from Rice University came up with a simple microneedle patch similar to a bandage to detect malaria, to reduce the burden of disease in countries struggling with poor health infrastructure in November 2020. The microneedles in the patch collect interstitial fluid containing few biomarkers that aids in detecting malaria. Thus, this boost the market growth.

Growing Strategic Alliances and Agreements

There have been growing alliances and agreements between organizations that lead to the immense growth of the market. For instance, ADVANZ PHARMA Corp. Limited entered into an agreement to acquire Correvio Pharma Corp which is a specialty pharmaceutical company in May 2020. The acquisition provided ADVANZ PHARMA with an immediate and direct commercial presence in France, Germany, Italy, Spain, and the Benelux region.

Highlights of Following Malaria Treatment Market Key Factors:-

Business description

A detailed description of the company's operations and business divisions

Corporate strategy

Analyst's summarization of the company's business strategy

Company history

Progression of key events associated with the company

Major products and services

A list of major products, services and brands of the company

Key competitors

A list of key competitors to the company

Important locations and subsidiaries

A list and contact details of key locations and subsidiaries of the company

Detailed financial ratios for the past 5 years

The latest financial ratios derived from the annual financial statements published by the company with 5 years' history.

Browse Related Reports:

About Data Bridge Market Research:

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. Wse are pleased with our glorious 99.9% customer satisfaction rating.

Contact Us: -

Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: - sopan.gedam@databridgemarketresearch.com

This release was published on openPR.